Pasithea Therapeutics Cor...
(KTTAW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | 486.56K | 15.06K | - |
Cost of Revenue | 648.45K | 113.19K | 17.27K | - |
Gross Profit | -648.45K | 373.36K | -2.21K | - |
Operating Income | -15.98M | -14.82M | -4.51M | -40.98K |
Interest Income | - | 102.00 | 508.00 | - |
Pretax Income | -15.51M | -13.94M | -2.17M | -40.98K |
Net Income | -15.96M | -13.06M | -2.17M | -40.98K |
Selling & General & Admin | 7.88M | 12.52M | 4.51M | 40.98K |
Research & Development | 8.10M | 2.67M | - | - |
Other Expenses | - | 44.72K | - | - |
Operating Expenses | 15.98M | 15.19M | 4.51M | 40.98K |
Interest Expense | - | 102.00 | 508.00 | - |
Selling & Marketing Expenses | -7.87B | 2.60M | - | - |
Cost & Expenses | 15.98M | 15.30M | 4.52M | 40.98K |
Income Tax | - | -879.97K | 508.00 | -61.48K |
Shares Outstanding (Basic) | 1.26M | 1.26M | 1.15M | 688.92K |
Shares Outstanding (Diluted) | 1.23M | 1.26M | 1.15M | 688.92K |
EPS (Basic) | -12.65 | -10.34 | -1.89 | -0.06 |
EPS (Diluted) | -13.01 | -10.34 | -1.89 | -0.06 |
EBITDA | -15.33M | -12.58M | -4.51M | - |
Depreciation & Amortization | 648.45K | 5.09K | 1.38K | 61.48K |